Francesca Tamarozzi Selected Research

Echinococcosis (Hydatid Cysts)

12/2021	Advances in the treatment, diagnosis, control and scientific understanding of taeniid cestode parasite infections over the past 50 years.
1/2021	Field Performance of a Rapid Diagnostic Test for the Serodiagnosis of Abdominal Cystic Echinococcosis in the Peruvian Highlands.
11/2020	Evaluation of the sensitivity and specificity of GST-tagged recombinant antigens 2B2t, Ag5t and DIPOL in ELISA for the diagnosis and follow up of patients with cystic echinococcosis.
1/2019	Role of microRNAs in host defense against Echinococcus granulosus infection: a preliminary assessment.
1/2019	Correction to: Role of microRNAs in host defense against Echinococcus granulosus infection: a preliminary assessment.
10/2018	Shortage of Albendazole and Its Consequences for Patients with Cystic Echinococcosis Treated at a Referral Center in Italy.
1/2018	Evaluation of the recombinant antigens B2t and 2B2t, compared with hydatid fluid, in IgG-ELISA and immunostrips for the diagnosis and follow up of CE patients.
12/2017	Preliminary Evaluation of Percutaneous Treatment of Echinococcal Cysts without Injection of Scolicidal Agent.
4/2016	Treatment of Hepatic Cystic Echinococcosis in Patients from the Southeastern Rhodope Region of Bulgaria in 2004-2013: Comparison of Current Practices with Expert Recommendations.
3/2016	Diagnostic Accuracy of Antigen 5-Based ELISAs for Human Cystic Echinococcosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Tamarozzi Research Topics

Disease

17	Echinococcosis (Hydatid Cysts) 12/2021 - 01/2011
14	Cysts 04/2022 - 06/2011
10	Infections 04/2022 - 10/2016
3	Onchocerciasis 02/2014 - 07/2011
2	Strongyloidiasis 04/2022 - 08/2021
2	Alveolar echinococcosis 11/2020 - 01/2018
2	Parasitic Diseases (Parasitic Disease) 01/2020 - 04/2016
2	Intestinal Volvulus (Volvulus) 10/2016 - 02/2014
1	Cysticercosis 01/2022
1	Neurocysticercosis 12/2021
1	COVID-19 12/2021
1	Schistosomiasis (Bilharziasis) 03/2021
1	Acalculous Cholecystitis 03/2021
1	Rheumatoid Arthritis 03/2021
1	Infectious Mononucleosis (Glandular Fever) 03/2021
1	Epstein-Barr Virus Infections 03/2021
1	Splenomegaly 03/2021
1	Hepatitis 03/2021
1	Reinfection 01/2021
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2021
1	Pulmonary Hypertension 01/2021
1	Disease Progression 01/2020
1	Loiasis 01/2019
1	Candidemia 12/2018
1	Neglected Diseases 10/2018
1	Fistula 12/2017
1	Sclerosing Cholangitis 12/2017
1	Fever (Fevers) 01/2016
1	Appendicitis 01/2016
1	Inflammation (Inflammations) 07/2011
1	Anaphylaxis (Anaphylactic Shock) 06/2011

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 04/2022 - 01/2014
9	Albendazole (Albenza)FDA Link 04/2022 - 09/2014
6	Pharmaceutical PreparationsIBA 01/2020 - 06/2011
4	Ivermectin (Mectizan)FDA Link 01/2019 - 07/2011
3	EnzymesIBA 04/2022 - 01/2021
3	ImmunosorbentsIBA 04/2022 - 01/2021
3	Praziquantel (Biltricide)FDA Link 12/2021 - 01/2021
3	Immunoglobulin G (IgG)IBA 08/2021 - 02/2016
2	AntibodiesIBA 01/2022 - 12/2021
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 01/2012
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2019
2	Doxycycline (Periostat)FDA LinkGeneric 10/2016 - 03/2012
1	Drinking WaterIBA 01/2022
1	COVID-19 VaccinesIBA 12/2021
1	BNT162 VaccineIBA 12/2021
1	BenzimidazolesIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	VaccinesIBA 12/2021
1	AgarIBA 08/2021
1	Immunoglobulins (Immunoglobulin)IBA 08/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2021
1	Transaminases (Aminotransferases)IBA 03/2021
1	InterleukinsIBA 01/2021
1	benzimidazoleIBA 01/2020
1	ORALIT (ORS)IBA 01/2019
1	EchinocandinsIBA 12/2018
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018
1	SolutionsIBA 12/2017
1	CausticsIBA 12/2017
1	Lipoproteins (Lipoprotein)IBA 10/2016
1	Complex MixturesIBA 03/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2016
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2016
1	Fluconazole (Zonal)FDA LinkGeneric 01/2016
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2016
1	Meropenem (Merrem)FDA LinkGeneric 01/2016
1	Interleukin-10 (Interleukin 10)IBA 02/2014
1	Interleukin-5 (Interleukin 5)IBA 02/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Interleukin-13IBA 01/2012
1	CytokinesIBA 01/2012
1	Biological ProductsIBA 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2011
1	Diethylcarbamazine (Hetrazan)FDA Link 07/2011

Therapy/Procedure

6	Therapeutics 01/2020 - 01/2013
3	Punctures 12/2017 - 01/2011
3	Drug Therapy (Chemotherapy) 03/2016 - 07/2011
1	Conservative Treatment 04/2022
1	Aftercare (After-Treatment) 01/2021
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2021
1	Operative Surgical Procedures 01/2021
1	Ligation 10/2016
1	Appendectomy 01/2016